Redmile Group

Immunome

Bothell

Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.

Zentalis

San Diego

Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.

Scholar Rock

Cambridge

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

Invivyd

New Haven

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Krystal Biotech

Pittsburgh

Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..

Absci

Vancouver

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

Stoke Therapeutics

Bedford

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

The Oncology Institute of Hope and Innovation

Cerritos

The Oncology Institute of Hope and Innovation is providing professional support for those affected by cancer and hematological malignancy.

Hansa Biopharma

Lund

Hansa Biopharma is a biopharmaceutical company that develops immunomodulatory treatments for people living with rare immunological diseases.

Ceribell

Sunnyvale

Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.

Genalyte

San Diego

Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.

Lycia Therapeutics

South San Francisco

Lycia is a Series B biotech company built on a platform developed by academic founder Professor Carolyn Bertozzi at Stanford, arising from Stanford research, with potential to deliver next-generation therapeutics for difficult-to-treat dise

ADARx Pharmaceuticals

San Diego

ADARx Pharmaceuticals, Inc., a San Diego-based clinical-stage biotechnology company, develops RNA-targeting platforms and oligonucleotide delivery technologies to inhibit, degrade, or edit disease-causing mRNA, pursuing programs across gene

Company dissolved

Plano

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.